• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从巴西自由野生鸟类中分离的弓形虫株的磺胺嘧啶和乙胺嘧啶的体外和体内敏感性。

In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds.

机构信息

Laboratório de Toxoplasmose, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Laboratório de Quimioterapia de Protozoários Egler Chiari, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte, Minas Gerais, 31270-901, Brazil.

出版信息

Sci Rep. 2023 May 5;13(1):7359. doi: 10.1038/s41598-023-34502-3.

DOI:10.1038/s41598-023-34502-3
PMID:37147353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10162961/
Abstract

Little is known about the existence of drug-resistant Toxoplasma gondii strains and their possible impact on clinic outcomes. To expand our knowledge about the existence of natural variations on drug susceptibility of T. gondii strains in Brazil, we evaluated the in vitro and in vivo susceptibility to sulfadiazine (SDZ) and pyrimethamine (PYR) of three atypical strains (Wild2, Wild3, and Wild4) isolated from free-living wild birds. In vitro susceptibility assay showed that the three strains were equally susceptible to SDZ and PYR but variations in the susceptibility were observed to SDZ plus PYR treatment. Variations in the proliferation rates in vitro and spontaneous conversion to bradyzoites were also accessed for all strains. Wild2 showed a lower cystogenesis capacity compared to Wild3 and Wild4. The in vivo analysis showed that while Wild3 was highly susceptible to all SDZ and PYR doses, and their combination, Wild2 and Wild4 showed low susceptibility to the lower doses of SDZ or PYR. Interestingly, Wild2 presented low susceptibility to the higher doses of SDZ, PYR and their combination. Our results suggest that the variability in treatment response by T. gondii isolates could possibly be related not only to drug resistance but also to the strain cystogenesis capacity.

摘要

关于耐药性弓形虫菌株的存在及其对临床结果的可能影响,人们知之甚少。为了扩大我们对巴西弓形虫菌株对药物敏感性的天然变异的了解,我们评估了从自由生活的野生鸟类中分离出的三种非典型菌株(Wild2、Wild3 和 Wild4)对磺胺嘧啶(SDZ)和乙胺嘧啶(PYR)的体外和体内敏感性。体外药敏试验表明,这三种菌株对 SDZ 和 PYR 同样敏感,但对 SDZ 加 PYR 治疗的敏感性存在差异。还评估了所有菌株的体外增殖率和自发转化为缓殖子的差异。与 Wild3 和 Wild4 相比,Wild2 的囊胞形成能力较低。体内分析表明,虽然 Wild3 对所有 SDZ 和 PYR 剂量及其组合均高度敏感,但 Wild2 和 Wild4 对较低剂量的 SDZ 或 PYR 敏感性较低。有趣的是,Wild2 对较高剂量的 SDZ、PYR 及其组合表现出较低的敏感性。我们的结果表明,弓形虫分离株的治疗反应的可变性可能不仅与耐药性有关,还与菌株的囊胞形成能力有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/6450ae6ca257/41598_2023_34502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/68560859936b/41598_2023_34502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/36239e79f34b/41598_2023_34502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/2225b30b55d5/41598_2023_34502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/7924e62e9082/41598_2023_34502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/6450ae6ca257/41598_2023_34502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/68560859936b/41598_2023_34502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/36239e79f34b/41598_2023_34502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/2225b30b55d5/41598_2023_34502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/7924e62e9082/41598_2023_34502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31df/10162961/6450ae6ca257/41598_2023_34502_Fig5_HTML.jpg

相似文献

1
In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds.从巴西自由野生鸟类中分离的弓形虫株的磺胺嘧啶和乙胺嘧啶的体外和体内敏感性。
Sci Rep. 2023 May 5;13(1):7359. doi: 10.1038/s41598-023-34502-3.
2
Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.磺胺嘧啶和乙胺嘧啶对巴西先天性疾病人类病例分离菌株所致实验性弓形虫病的治疗效果
Exp Parasitol. 2019 Jul;202:7-14. doi: 10.1016/j.exppara.2019.05.001. Epub 2019 May 8.
3
Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.从巴西米纳斯吉拉斯州先天性弓形虫病新生儿中分离出的磺胺嘧啶耐药和敏感弓形虫分离株的基因多态性和表型特征
PLoS One. 2017 Jan 24;12(1):e0170689. doi: 10.1371/journal.pone.0170689. eCollection 2017.
4
Inhibition of by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.基于 1,2,4-三唑的化合物对 的抑制作用:与标准治疗药物嘧啶和磺胺嘧啶相比,选择性有显著提高。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2621-2634. doi: 10.1080/14756366.2022.2112576.
5
In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.不同基因型弓形虫菌株对乙胺嘧啶、磺胺嘧啶和阿托伐醌的体外敏感性
Antimicrob Agents Chemother. 2008 Apr;52(4):1269-77. doi: 10.1128/AAC.01203-07. Epub 2008 Jan 22.
6
Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.刚地弓形虫:氟康唑联合磺胺嘧啶和乙胺嘧啶对急性弓形虫病小鼠模型的影响。
Exp Parasitol. 2013 Mar;133(3):294-9. doi: 10.1016/j.exppara.2012.12.011. Epub 2012 Dec 25.
7
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.羟萘醌阿托伐醌单独或与乙胺嘧啶、磺胺嘧啶、克拉霉素或米诺环素联合使用对刚地弓形虫的体外和体内活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2371-8. doi: 10.1128/AAC.37.11.2371.
8
Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.阿托伐醌和磺胺嘧啶对感染巴西分离的刚地弓形虫菌株的小鼠的治疗效果。
Parasite. 2005 Jun;12(2):171-7. doi: 10.1051/parasite/2005122171.
9
Induction of sulfadiazine resistance in vitro in Toxoplasma gondii.弓形虫体外诱导磺胺嘧啶耐药性。
Exp Parasitol. 2013 Feb;133(2):131-6. doi: 10.1016/j.exppara.2012.11.019. Epub 2012 Dec 1.
10
New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.研究抗菌药物对刚地弓形虫作用的新微量法:磺胺多辛和磺胺嘧啶单独及与乙胺嘧啶联合使用的比较以及克林霉素、甲硝唑和环孢素A的研究
Antimicrob Agents Chemother. 1984 Jul;26(1):26-30. doi: 10.1128/AAC.26.1.26.

引用本文的文献

1
N-(9-Acridinyl) Amino Acid Derivatives: Synthesis and In Vitro Evaluation of Anti- Activity.N-(9-吖啶基)氨基酸衍生物:抗活性的合成与体外评价
Pharmaceutics. 2025 Mar 15;17(3):374. doi: 10.3390/pharmaceutics17030374.
2
Antiproliferative and Morphological Analysis Triggered by Drugs Contained in the Medicines for Malaria Venture COVID-Box Against Tachyzoites.疟疾防治创新联盟新冠药盒中含有的药物对速殖子引发的抗增殖及形态学分析
Microorganisms. 2024 Dec 16;12(12):2602. doi: 10.3390/microorganisms12122602.
3
BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in to Pyrimethamine Treatment.

本文引用的文献

1
Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.南美洲的刚地弓形虫:传播方式、种群结构和临床表现的差异模式。
Parasitol Res. 2021 Sep;120(9):3065-3076. doi: 10.1007/s00436-021-07282-w. Epub 2021 Aug 14.
2
Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.磺胺嘧啶和乙胺嘧啶对巴西先天性疾病人类病例分离菌株所致实验性弓形虫病的治疗效果
Exp Parasitol. 2019 Jul;202:7-14. doi: 10.1016/j.exppara.2019.05.001. Epub 2019 May 8.
3
Genetic diversity of isolates obtained from free-living wild birds rescued in Southeastern Brazil.
BONCAT-iTRAQ标记揭示了对乙胺嘧啶治疗的适应性反应的分子标志物。
Pathogens. 2024 Oct 8;13(10):879. doi: 10.3390/pathogens13100879.
4
Rapid genotyping of Toxoplasma gondii isolates via Nanopore-based multi-locus sequencing.通过基于纳米孔的多位点测序对弓形虫分离株进行快速基因分型。
AMB Express. 2024 Jun 6;14(1):68. doi: 10.1186/s13568-024-01728-x.
从巴西东南部获救的自由生活野生鸟类中分离出的菌株的遗传多样性。
Int J Parasitol Parasites Wildl. 2018 Nov 10;7(3):432-438. doi: 10.1016/j.ijppaw.2018.11.001. eCollection 2018 Dec.
4
Drugs in development for toxoplasmosis: advances, challenges, and current status.正在研发的治疗弓形虫病的药物:进展、挑战与现状
Drug Des Devel Ther. 2017 Jan 25;11:273-293. doi: 10.2147/DDDT.S60973. eCollection 2017.
5
Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.从巴西米纳斯吉拉斯州先天性弓形虫病新生儿中分离出的磺胺嘧啶耐药和敏感弓形虫分离株的基因多态性和表型特征
PLoS One. 2017 Jan 24;12(1):e0170689. doi: 10.1371/journal.pone.0170689. eCollection 2017.
6
Apicoplast fatty acid synthesis is essential for pellicle formation at the end of cytokinesis in Toxoplasma gondii.顶质体脂肪酸合成对于刚地弓形虫胞质分裂末期表膜的形成至关重要。
J Cell Sci. 2016 Sep 1;129(17):3320-31. doi: 10.1242/jcs.185223. Epub 2016 Jul 25.
7
Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern Brazil.从巴西东北部家畜中分离出的刚地弓形虫分离株的致病性和磺胺嘧啶表型耐药性
Mem Inst Oswaldo Cruz. 2016 Jun 3;111(6):391-8. doi: 10.1590/0074-02760150459.
8
Lytic Cycle of Toxoplasma gondii: 15 Years Later.弓形虫的裂解周期:15年后
Annu Rev Microbiol. 2015;69:463-85. doi: 10.1146/annurev-micro-091014-104100. Epub 2015 Aug 28.
9
Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse.磺胺嘧啶与达拉匹林对小鼠实验性弓形虫病的协同作用。
Antibiot Chemother (Northfield). 1953 May;3(5):483-90.
10
Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters.弓形虫对磺胺嘧啶的耐药性:治疗靶点和ABC转运蛋白基因的过表达或多态性与之无关。
Parasite. 2013;20:19. doi: 10.1051/parasite/2013020. Epub 2013 May 27.